scholarly journals Determination of Injection Site in Flexor Digitorum Longus for Effective and Safe Botulinum Toxin Injection

2015 ◽  
Vol 39 (1) ◽  
pp. 32 ◽  
Author(s):  
Hong Geum Kim ◽  
Myung Eun Chung ◽  
Dae Heon Song ◽  
Ju Yong Kim ◽  
Bo Mi Sul ◽  
...  
2019 ◽  
Vol 98 (6) ◽  
pp. 351-355 ◽  
Author(s):  
Stephen R. Chorney ◽  
Jennifer A. Villwock ◽  
Amar C. Suryadevara

Botulinum toxin is the most commonly performed facial cosmetic procedure and pain at the injection site is a frequent patient concern. While various topical interventions have been described for analgesia, there have not been any studies comparing different techniques. We compared the use of a vibratory stimulus, ice pack application, and no intervention on injection site pain for cosmetic botulinum toxin injection. A prospective-, randomized-, individual-controlled study was conducted using a visual analog scale to assess pain. Patients received bilateral glabellar injections, with randomization into unilateral vibration, unilateral ice application, or vibration and ice on either side. We analyzed 88 injections on 22 patients. Mean visual analog scores were 26.5 (standard deviation [SD]: 23.1) among injections with vibration, 24.4 (SD: 22.9) with ice, and 29.4 (SD: 27.1) without analgesia. There was no significant difference in pain scale scores with the use of vibration, ice, or no topical anesthesia ( P = .737). Further, pain scale scores did not differ significantly between medial and lateral injections nor did patients have a reduction in pain on either side of the forehead regardless of which method was used. While there may be a role for topical interventions to improve injection site analgesia, we maintain that consistently proper technique plays a greater role in improving patient tolerance. Future studies will continue to investigate the role of topical anesthesia in cosmetic facial injections and address patient-specific factors contributing to discomfort.


2006 ◽  
Vol 15 (6) ◽  
pp. 414-417 ◽  
Author(s):  
Michael J. Oddy ◽  
Christopher Brown ◽  
Rikki Mistry ◽  
Deborah M. Eastwood

Toxins ◽  
2017 ◽  
Vol 9 (11) ◽  
pp. 375 ◽  
Author(s):  
Alessandro Picelli ◽  
Alessio Baricich ◽  
Elena Chemello ◽  
Nicola Smania ◽  
Carlo Cisari ◽  
...  

The tibialis posterior muscle is a frequent target for injection of botulinum toxin during the management of spastic equinovarus foot in adults with post-stroke spasticity. Although it is deep-seated, the needle insertion into the tibialis posterior muscle is usually performed using anatomical landmarks and safety information obtained from healthy subjects and cadavers. Our aim was to evaluate the botulinum toxin injection site for the medial approach to the tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot. Forty-six patients were evaluated at the affected middle lower leg medial surface with ultrasonography according to the following parameters: tibialis posterior muscle depth, thickness, and echo intensity. As to the spastic tibialis posterior, we found a mean muscle depth of 26.5 mm and a mean muscle thickness of 10.1 mm. Furthermore we observed a median tibialis posterior muscle echo intensity of 3.00 on the Heckmatt scale. The tibialis posterior muscle thickness was found to be inversely associated with its depth (p < 0.001) and echo intensity (p = 0.006). Furthermore, tibialis posterior muscle depth was found to be directly associated with its echo intensity (p = 0.004). Our findings may usefully inform manual needle placement into the tibialis posterior for the botulinum toxin treatment of spastic equinovarus foot in chronic stroke patients.


Sign in / Sign up

Export Citation Format

Share Document